Summary

The association between diabetes and elevated cancer risk is of increasing concern. Some investigators suggest that in addition to the pathology of type 2 diabetes mellitus, the diabetes treatments themselves may play a malignant role. These issues, as highlighted in recent journal and mass media articles as well as in conjunction with the release of a related consensus statement from the American Diabetes Association are discussed.